ArticleNutrition research and practice2026
Anti-cancer effect of estradiol and β-carotene in human colon cancer cells.
Article in Nutrition research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesColorectal cancer (CRC) is a common malignancy worldwide and continues to account for significant cancer-associated morbidity and mortality. This study aimed to explore the anti-cancer effects of estradiol (E2), a female hormone, and β-carotene (BC), a dietary antioxidant, focusing on their roles in promoting apoptosis and regulating the expression of BC-related metabolic enzymes in human colon cancer cells. MATERIALS/
methodsE2, BC, and a combination of both were administered to 2 human colon cancer cell lines, HCT116 and HT29. Cell survival was analyzed using the MTT assay. Expression of estrogen receptor beta (ERβ), β,β-carotene-15',15'-monooxygenase 1 (BCMO1), β,β-carotene-9',10'-oxygenase 2 (BCO2), and apoptosis-related markers such as Bcl-2 (anti-apoptotic) and Bax (pro-apoptotic) was analyzed using polymerase chain reaction or Western blotting.
resultsE2 treatment decreased cell viability in both cell lines, indicating that E2 promotes anti-cancer effects. BC treatment modestly increased E2 secretion, while the combined E2 and BC treatment enhanced this effect. Treatment with E2, BC, and their combination suppressed Bcl-2 expression and upregulated Bax. The combination treatment was more effective than each treatment administered individually. Furthermore, treatment with E2, BC, and their combination upregulated the expression of ERβ, BCMO1, and BCO2.
conclusionThe anti-cancer effects of E2, BC, and their combination are mediated through apoptosis induction. These findings highlight the potential for utilizing dietary antioxidants and hormonal regulation as complementary strategies in CRC treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.